Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Gao, Jian ^a   Hu, Zhenhua ^a   Liu, Dawo ^a   Liu, Juanjuan ^a   Liu, Chuan ^a   Hou, Rui ^a   Gao, Song ^a   Zhang, Danye ^a   Zhang, Shulan ^a   Lin, Bei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapeutic Drug Resistance; Integrin v, 3; Lewis y Antigen; Ovarian Cancer

Indexed keywords

ANTIGEN; BETA3 INTEGRIN; BIOLOGICAL MARKER; CD51 ANTIGEN; LEWIS Y ANTIGEN; PARAFFIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER STAGING; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; TISSUE SECTION;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAV; INTEGRIN BETA3; LEWIS BLOOD-GROUP SYSTEM; NEOPLASM GRADING; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 84878371281     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-36     Document Type: Article

References (19)

1. Adhesion molecules. Skubitz AP, Cancer Treat Res 2002 107 305 329 11775459
2. Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Hazlehurst LA, Dalton WS, Cancer Metastasis Rev 2001 20 43 50 10.1023/A:1013156407224 11831646 (Pubitemid 34074677)
3. Integrins as novel drug targets for overcoming innate drug resistance. Damiano JS, Curr Cancer Drug Targets 2002 2 37 43 10.2174/1568009023334033 12188919 (Pubitemid 34627377)
4. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. Moro L, Venturino M, Bozzo C, Silenqo L, Altruda F, Bequinot L, et al. EMBO J 1998 17 6622 6632 10.1093/emboj/17.22.6622 9822606 (Pubitemid 28521796)
5. Integrin beta4 signaling promotes tumor angiogenesis. NikoloPoulos SN, Blaikie P, Yoshioka T, Guo W, Giancotti FG, Cancer Cell 2004 6 471 483 10.1016/j.ccr.2004.09.029 15542431 (Pubitemid 39469983)
6. Study on the expression and clinical significances of Lewis y antigen and integrin αv, β3 in epithelial ovarian tumors. Wang Y, Liu J, Lin B, Wang C, Li Q, Liu S, et al. Int J Mol Sci 2011 12 3409 3421 10.3390/ijms12063409 21747684
7. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. Taylor ST, Hickman JA, Dive C, J Natl Cancer Inst 2000 92 18 23 10.1093/jnci/92.1.18 10620629 (Pubitemid 30082224)
8. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. Science 1997 275 1943 1947 10.1126/science.275.5308.1943 9072974 (Pubitemid 27148818)
9. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23. 3 that is mutated in multiple advanced cancer. Steck PA, Perhouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al. Nat Genet 1997 15 356 362 10.1038/ng0497-356 9090379 (Pubitemid 27147102)
10. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS, Blood 1999 93 1658 1667 10029595 (Pubitemid 29102494)
11. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen. Zhang F, Liu J, Lin B, Liu Q, Zhao Y, Zhu L, et al. Int J Mol Sci 2011 12 7323 7334 10.3390/ijms12117323 22174601
12. Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the α1,2-fucosyltransferase gene. Iwamori M, Tanaka K, Kubushiro K, Lin B, Kiquchi K, Ishiwata I, et al. Cancer Sci 2005 96 1 26 30 10.1111/j.1349-7006. 2005.00005.x 15649251 (Pubitemid 40310021)
13. Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of asparagine-linked glycans at the surface of NIH 3 T3 cells expressing the N-ras proto-oncogene. Easton EW, Bolsche JG, van den Eijnden DH, J Boil Chem 1991 266 21674 21680 (Pubitemid 121000233)
14. Deletion of core fucosylation on α§ssub§3§esub§ β§ssub§1§esub§ integrin down-regulates its functions. Zhao Y, Itoh S, Wang X, Miyoshi E, Kariya Y, Miyazaki K, et al. J Boil Chem 2006 281 50 38343 38350 10.1074/jbc.M608764200 (Pubitemid 46041957)
15. Enhancement of the adhesive and spreading potentials of ovarian carcinoma RMG-1 cells due to increased expression of integrin a5β1with the LewisY-structure on transfection of the a1, 2-fucosyltransferase gene. Yan LM, Lin B, Zhu LC, Hao YY, Qi Y, Wang CZ, et al. Biochimie 2010 92 852 857 10.1016/j.biochi.2010.02.012 20172014
16. Expression and Correlation of Lewis y Antigen and Integrins a5 and β1 in Ovarian Serous and Mucinous Carcinoma. Li Q, Liu S, Lin B, Yan L, Wang Y, Wang C, et al. Int J Gynecol Cancer 2010 20 1482 1489 21119363
17. Overexpression of Lewis (y) antigen protects ovarian cancer RMG-1 cells from carboplatin-induced apoptosis by the Upregulation of Topo-I and Topo-II b. Wang C, Yan L, Wang Y, Lin B, Liu S, Li Q, et al. The anatomical record 2011 294 961 969 10.1002/ar.21398 21542140
18. Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line. Maubant S, Cruet-Hennequart S, Poulain L, Carreiras F, Sichel F, Luis J, et al. Int J Cancer 2002 97 186 194 10.1002/ijc.1600 11774263 (Pubitemid 34019954)
19. Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I. Gao L, Yan L, Lin B, Gao J, Liang X, Wang Y, et al. J Exp Clin Cancer Res 2011 30 1 15 10.1186/1756-9966-30- 15 21294926